Zentralbl Chir 2021; 146(S 01): S50
DOI: 10.1055/s-0041-1733355
Abstracts

V-108 Neoadjuvant prehabilitation therapy for locally advanced non-small-cell lung cancer: Optimizing outcomes throughout the trajectory of care

S Schmid
1   Universitätsklinikum Freiburg, Klinik für Thoraxchirurgie, Freiburg, Deutschland
2   McGill University Health Centre, Division of Thoracic Surgery, Montreal, Kanada
,
EM Minnella
3   McGill University Health Centre, Department of Anesthesia, Montreal, Kanada
,
S Najmeh
2   McGill University Health Centre, Division of Thoracic Surgery, Montreal, Kanada
,
J Cools-Lartigue
2   McGill University Health Centre, Division of Thoracic Surgery, Montreal, Kanada
,
L Ferri
2   McGill University Health Centre, Division of Thoracic Surgery, Montreal, Kanada
,
D Mulder
2   McGill University Health Centre, Division of Thoracic Surgery, Montreal, Kanada
,
C Sirois
2   McGill University Health Centre, Division of Thoracic Surgery, Montreal, Kanada
,
S Owen
3   McGill University Health Centre, Department of Anesthesia, Montreal, Kanada
,
F Carli
3   McGill University Health Centre, Department of Anesthesia, Montreal, Kanada
,
J Spicer
2   McGill University Health Centre, Division of Thoracic Surgery, Montreal, Kanada
› Author Affiliations
› Further Information
Also available at
 

Hintergrund

Prehabilitation is well established for improving outcomes in cancer surgery. Combining prehabilitation with neoadjuvant treatments may provide an opportunity to rapidly initiate cancer-directed therapy while improving functional status in preparation for local consolidation. In this proof-of-concept study, we analyzed non-small-cell lung cancer patients who underwent simultaneous prehabilitation and neoadjuvant therapy.



Publication History

Article published online:
06 September 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany